F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

August 27, 2026 · 1:58 pm 2 sources

Image: The New York Times

Coverage

Wires & papers of record

• New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
  The New York Times · August 27, 2026 09:02
  Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
• F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
  The New York Times · August 27, 2026 13:58
  In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.